{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:31:31Z","timestamp":1794339091504,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010740","name":"Asahi Kasei Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jbspin.2023.105680","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T02:56:02Z","timestamp":1703213762000},"page":"105680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: A cohort study using routinely collected health data"],"prefix":"10.1016","volume":"91","author":[{"given":"Yoshiya","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Uenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2023.105680_bib0165","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","article-title":"Polymyalgia rheumatica","volume":"390","author":"Gonz\u00e1lez-Gay","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2023.105680_bib0170","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism\/American college of rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2023.105680_bib0175","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European league against rheumatism\/American college of rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2023.105680_bib0180","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep395","article-title":"Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study","volume":"49","author":"Mackie","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2023.105680_bib0185","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.2147\/IJGM.S322111","article-title":"Withdrawal of glucocorticoid therapy is difficult in women with polymyalgia rheumatica: an observational study","volume":"14","author":"Aoki","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jbspin.2023.105680_bib0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/mr\/roac024","article-title":"Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset","volume":"33","author":"Nawata","year":"2023","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0195","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3899\/jrheum.110851","article-title":"Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study","volume":"39","author":"Mazzantini","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12916-017-0987-1","article-title":"Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study","volume":"16","author":"Paskins","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.jbspin.2023.105680_bib0205","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1007\/s10067-020-05129-w","article-title":"Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study","volume":"39","author":"Singh","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0210","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica","volume":"40","author":"Gabriel","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2023.105680_bib0215","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1253\/circj.CJ-13-0702","article-title":"Cardiovascular disease epidemiology in Asia: an overview","volume":"77","author":"Ohira","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jbspin.2023.105680_bib0220","unstructured":"Guideline IH. General principles for planning and design of multi-regional clinical trials E17 2016."},{"key":"10.1016\/j.jbspin.2023.105680_bib0225","unstructured":"Medical and Healthcare Database Utilization Committee, Japanese Society for Pharmacoepidemiology. Survey of Japanese databases in Japan available for clinical\/pharmacoepidemiology, http:\/\/www.jspe.jp\/committee\/020\/0210\/ [accessed 05.08.23]."},{"key":"10.1016\/j.jbspin.2023.105680_bib0230","first-page":"road026","article-title":"Clinical features of polymyalgia rheumatica patients in Japan: analysis of real-world data from 2015 to 2020","author":"Tanaka","year":"2023","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2188\/jea.JE20200288","article-title":"History and profile of diagnosis procedure combination (DPC): development of a real data collection system for acute inpatient care in Japan","volume":"31","author":"Hayashida","year":"2021","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0240","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2183\/pjab.98.026","article-title":"Clinical epidemiology and pharmacoepidemiology studies with real-world databases","volume":"98","author":"Yoshida","year":"2022","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.jbspin.2023.105680_bib0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10916-008-9220-2","article-title":"Impact of the Japanese diagnosis procedure combination-based payment system in Japan","volume":"34","author":"Wang","year":"2010","journal-title":"J Med Syst"},{"key":"10.1016\/j.jbspin.2023.105680_bib0250","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.mayocp.2019.12.004","article-title":"Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus other classes of glucose-lowering medications on renal outcome in type 2 diabetes","volume":"95","author":"Takeuchi","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jbspin.2023.105680_bib0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/phar.2761","article-title":"Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: a case-crossover study","volume":"43","author":"Ri","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jbspin.2023.105680_bib0260","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/endrev\/bnab007","article-title":"Conducting real-world evidence studies on the clinical outcomes of diabetes treatments","volume":"42","author":"Schneeweiss","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jbspin.2023.105680_bib0265","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s40744-019-00180-9","article-title":"Risk of potential glucocorticoid-related adverse events in patients with giant cell arteritis: results from a USA-based electronic health records database","volume":"6","author":"Best","year":"2019","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jbspin.2023.105680_bib0270","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/aje\/kwac115","article-title":"A framework for descriptive epidemiology","volume":"191","author":"Lesko","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0275","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/aje\/kwac056","article-title":"On the need to revitalize descriptive epidemiology","volume":"191","author":"Fox","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0280","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/ije\/dys223","article-title":"Why representativeness should be avoided","volume":"42","author":"Rothman","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0285","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13075-018-1757-y","article-title":"Comorbidities in polymyalgia rheumatica: a systematic review","volume":"20","author":"Partington","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2023.105680_bib0290","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1080\/14656566.2019.1651840","article-title":"Recent prescription status of oral analgesics in Japan in real-world clinical settings: retrospective study using a large-scale prescription database","volume":"20","author":"Ushida","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jbspin.2023.105680_bib0295","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s10067-014-2650-y","article-title":"Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy","volume":"35","author":"Mori","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0300","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40744-018-0112-8","article-title":"Risk associated with cumulative oral glucocorticoid use in patients with giant cell arteritis in real-world databases from the USA and UK","volume":"5","author":"Gale","year":"2018","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jbspin.2023.105680_bib0305","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","article-title":"Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force","volume":"75","author":"Strehl","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2023.105680_bib0310","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3899\/jrheum.101149","article-title":"The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases","volume":"38","author":"Bernatsky","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0315","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"2017 American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105680_bib0320","unstructured":"Shionogi & Co., Ltd. Package insert of prednisolone [cited 2022 Mar 4], Available from:https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/343018_2456001F1310_4_02."}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X23001598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X23001598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:32:15Z","timestamp":1761150735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X23001598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1297319X23001598"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2023.105680","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: A cohort study using routinely collected health data","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2023.105680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"105680"}}